Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | |
|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||
| Cash flow from continuing operating activities | 2.2K | -56.06K | -5.24K |
| Net income from continuing operations | ---77.92K | ---70.04K | ---37.95K |
| Other non cashItems | --67.68K | --14.83K | --30.57K |
| Change In working capital | --12.44K | ---844 | --2.14K |
| -Change in receivables | ---688 | ---2.46K | --1.24K |
| -Change in payables and accrued expense | --13.13K | --1.62K | --897 |
| Cash from discontinued investing activities | |||
| Operating cash flow | --2.2K | ---56.06K | ---5.24K |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 0 | -8.5K | -10.84K |
| Net other investing changes | --0 | ---8.5K | ---10.84K |
| Cash from discontinued investing activities | |||
| Investing cash flow | --0 | ---8.5K | ---10.84K |
| Financing cash flow | |||
| Cash flow from continuing financing activities | -30.89K | ||
| Net issuance payments of debt | --0 | ---- | ---- |
| Net common stock issuance | --0 | ---- | ---- |
| Cash from discontinued financing activities | |||
| Financing cash flow | ---30.89K | ---- | ---- |
| Net cash flow | |||
| Beginning cash position | --428.13K | --242.69K | --258.77K |
| Current changes in cash | ---28.69K | --185.45K | ---16.08K |
| End cash Position | --399.45K | --428.13K | --242.69K |
| Free cash from | --2.2K | ---56.06K | ---5.24K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.